CK19 immunoexpression in extrapancreatic endocrine tumours of the gastrointestinal tract

Histopathology

Volumn 55, Issue 1, 2009, Pages 116-120

  Chetty, Runjan ^a   Serra, Stefano ^a   Jain, Richa ^a   Evans, Mark ^b   Cooper, Kumarasen ^b   Iyer, Anita ^b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19;

ADULT; AGED; CANCER LOCALIZATION; CLINICAL FEATURE; CONTROLLED STUDY; ENDOCRINE TUMOR; FEMALE; GASTROINTESTINAL TRACT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LETTER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ENDOCRINE GLAND NEOPLASMS; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; KERATIN-19; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 68049138055     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03328.x     Document Type: Letter

References (10)

1. Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL. Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod. Pathol. 2001 14 338 342.
2. Uenishi T, Kubo S, Yamamoto T et al. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci. 2003 94 851 857.
3. Bhatavdekar JM, Patel DD, Chikhlikar PR et al. Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma. Dis. Colon Rectum 2001 44 523 533.
4. Deshpande V, Fernandez-del Castillo C, Muzikansky A et al. Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors. Am. J. Surg. Pathol. 2004 28 1145 1153.
5. Ali A, Serra S, Asa SL, Chetty R. The diagnostic utility of CK19 and CD99 in pancreatic endocrine tumors. Am. J. Surg. Pathol. 2006 30 1588 1594.
6. La Rosa S, Rigoli E, Uccella S, Novario R, Capella C. Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumours. Histopathology 2007 50 597 601.
7. Schmitt AM, Anlauf M, Rousson V et al. WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors. Am. J. Surg. Pathol. 2007 31 1677 1682.
8. Solcia E, Kloppel G, Sobin LH. Histological typing of endocrine tumours. New York : Springer, 2000.
9. Rindi G, Kloppel G, Ahlman H et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006 449 395 401.
10. Rindi G, Kloppel G, Couvelard A et al. TNM staging of midgut and hindgut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2007 451 757 762.